Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02004028
Title Window of Opportunity Study of VS-6063 (Defactinib) in Participants With Surgical Resectable Malignant Pleural Mesothelioma.
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verastem, Inc.
Indications

malignant pleural mesothelioma

Therapies

Defactinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.